Goldman Sachs Group Inc Amarin Corp Plcuk Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Goldman Sachs Group Inc holds 56,498 shares of AMRN stock, worth $29,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,498
Previous 71,647
21.14%
Holding current value
$29,378
Previous $45,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding AMRN
# of Institutions
181Shares Held
69.6MCall Options Held
258KPut Options Held
98K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$12.9 Million3.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$6.46 Million0.64% of portfolio
-
Eversept Partners, LP New York, NY3.31MShares$1.72 Million0.16% of portfolio
-
Morgan Stanley New York, NY2.55MShares$1.32 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.3 Million1.16% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $210M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...